FENNEC PHARMACEUTICALS INC. (FENC) Return on equity 2016–2025
FENNEC PHARMACEUTICALS INC. (FENC) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-27461.1%FY2025 · since FY2016: -78.1% → -27461.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -27461.1% | — |
| FY2020 | -62.3% | +45.3 pp |
| FY2019 | -107.6% | -61.2 pp |
| FY2018 | -46.4% | -20.1 pp |
| FY2017 | -26.3% | +51.8 pp |
| FY2016 | -78.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice